Clinical Trial Update: Efficacy and Safety of Azilsartan Compared to Olmesartan Medoxomil in Chinese Participants With Grade I or II Essential Hypertension [Phase 3]

View source ↗

Summary

A Phase 3 trial in Chinese adults with essential hypertension compares azilsartan to olmesartan medoxomil to assess efficacy and safety outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• Azilsartan (azilsartan)
• OLMESARTAN MEDOXOMIL (olmesartan medoxomil)

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Essential Hypertension | Phase 3 | Status: UNKNOWN